Design and Molecular Simulation of a Rituximab-Methimazole Hybrid Compound for Selective Thyroid-Stimulating Hormone Receptor Inhibition in Graves’ Disease [Internet]. SciELO Preprints. 2025 [citado 14º de maio de 2026]. Disponível em: https://preprints.scielo.org/index.php/scielo/preprint/view/12615